Diagnostic and Biotech

New Frontiers in the European Cancer Diagnostics Market: Business Challenges, Emerging Technologies, Competitive Landscape

  • VPG16131
  • 0 Pages
  • May 2014
  • Diagnostic and Biotech

Complete report $19,700. DataPack (test volumes, sales forecasts, supplier shares) $12,800.


New Frontiers in the European Cancer Diagnostics Market: Business Challenges, Emerging Technologies, Competitive Landscape is Venture Planning Groups new study of the major business opportunities emerging in the European cancer diagnostics market during the nextfive years. The report examines trends in major European countries; reviews current and emerging assays; analyzes potential applications of new diagnostic technologies; forecasts sales of major tumor markers by country and market segment; profiles leading players and potential market entrants; and identifies specific business opportunities for suppliers.


Rationale


The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease. During the next five years, the worldwide cancer diagnostics market is promising to be an exciting, dynamic and rapidly expanding field. Anticipated technological breakthroughs will create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The rise in geriatric population will further compound the growing demand for malignancy assays and the rapid market expansion worldwide.


Geographic Coverage


France, Germany, Italy, Spain, UK


European Market Overview


- Five-year test volume and sales projections by country.


- Comprehensive market segmentation analysis, including review

of the market dynamics, structure, size, growth and major suppliers

by country.


- Estimated universe of laboratories performing cancer diagnostic testing

by country.


- Cancer statistics, etiology and recent developments.


Business Opportunities and Strategic Recommendations


- Specific new product development opportunities with potentially

significant market appeal during the next five years.


- Design criteria for new products.


- Alternative market penetration strategies.


- Potential market entry barriers and risks.


Over 200 Current and Emerging Cancer Diagnostic Test


- Biochemical Markers

- Oncogenes

- Growth Factors

- Hormones

- Colony Stimulating Factors

- Lymphokines

- Immunohistochemical Stains, and others.


- ACTH, AFP, Beta-2 Microglobulin, CA 15-3/27.29, CA 19-9, CA 125, Calcitonin, Cathepsin, CEA,

Chromogranin, Colon-Specific Antigen, Cytokeratins, Estrogen Receptor, Ferritin, Gastrin, HCG,

Insulin, Interferons, Interleukins, Lymphocyte Subtyping, Neuron-Specific Enolase, Nucleolar,

Occult Blood, Oncogenes, Pancreatic Oncofetal Antigen, Pap Smear, Parathyroid Hormone,

Progesterone Receptor, Prostatic Acid Phosphatase, Prostatic Specific Antigen, S-100 Protein,

Serotonin, Sialic Acid, Squamous Cell Carcinoma Ag, TDT, Thymidine Kinase, Thyroglobulin,

Tissue Polypeptide Antigen, and others.


Supplier Shares, Sales and Volume Forecasts


- Sales and market shares of major cancer diagnostic product

suppliers by individual test and country.


- Five-year test volume and sales forecasts

for major tumor markers by country and market segment, including:


- Hospitals

- Commercial/Private Laboratories

- Physician Offices/Group Practices


Instrumentation Review


- Analysis of major molecular diagnostic and immunodignostic analyzers

used for cancer testing, including their operating characteristics,

features and selling prices.


Technology Assessment


- Assessment of latest molecular diagnostic methods,

biochips/microarrays, biosensors, monoclonal antibodies, immunoassays,

chromosome analysis, IT, artificial intelligence, flow cytometry, and other technologies

and their potential applications for cancer diagnostic testing.


- Review of competing/complementing technologies, including

CT, MRI, NMR, PET and photonics spectroscopy.


- Extensive listings of companies, universities and research centers

developing new cancer diagnostic tests and detection technologies.


Competitive Strategies


- Strategic assessments ofmajor suppliers

and start-up firms developing innovative

technologies and products, including their sales,

product portfolios, marketing tactics, collaborative

arrangements, and new products in R&D.


- Companies analyzed in the report include



- Abbott

- AdnaGen

- Agilent Technologies

- Applied Gene Technologies

- Arca/Nuvelo

- Beckman Coulter/Danaher

- Becton Dickinson

- Biomedical Diagnostics

- bioMerieux

- Bio-Rad

- CellSearch

- Cepheid

- Correlogic Systems/Vermillion

- Decode

- Diadexus

- Diagnocure

- DiaSorin

- Eiken Chemical

- Epigenomics

- Enterix

- Enzo Biochem

- Exact Sciences

- Fujirebio/Innogenetics

- Guided Therapeutics

- Hologic/Gen-Probe

- Kreatech

- Kyowa Medex

- Mackay Life Sciences

- Myriad Genetics

- Nanogen Elitech

- OncoLab

- Ortho-Clinical Diagnostics

- Panacea Pharmaceuticals

- Polartechnics

- Polymedco

- PreMD

- Qiagen/Ipsogen

- Quest Diagnostics

- Radient Pharmaceuticals

- Roche

- Scienion

- Sequenom

- Siemens Healthcare

- Takara Bio

- Targeted Diagnostics & Therapeutics

- Thermo Fisher/Life Technologies

- Tosoh

- Veridex

- Wako Pure Chemicals

- Wallac/PE

- Zilla


Contains 820 pages and 320 tables

Please Select Format

Need More Information

Contact us
+ 1-800-910-6452
+1-971-202-1575
+91 20 66346066
--- or ---
help@bigmarketresearch.com

 

UPCOMING MARKET RESEARCH REPORTS

Global C-Reactive Protein Testing Market (Application, Types of Assays and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2012 - 2020

C-Reactive Protein Tests are blood tests that measure the levels of C-Reactive Protein. C-reactive protein is a protein that is produced by the liver and its level increase when there ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

Global Forensic Technologies Market (Service, Products and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2012 - 2020

Forensic technology is used for identification, interpretation and assessment of substantial evidences gathered from site of crime. Forensic science has witnessed tremendous developments in its technologies which in turn have ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

Global Renal Biomarkers Market (Marker Type, Assay Platform, Application and Geography) - Size, Share, Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2014 - 2020

Renal biomarkers help diagnose or identify the patients at risk of developing kidney diseases, by measuring their blood or urine levels. They are commonly released in acute or chronic kidney ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

World Live Cell Imaging Market - Opportunities and Forecast, 2014 - 2020

Live cell imaging is the study of cells in real time using the images obtained from screening systems and microscopes. The technology has altered the approach of scientists to study ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

Global Medical Image Processing Market (Application, Image Type, Technology and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2014 - 2021

Medical imaging is a technique used for the creating the visual representation of the internal body parts for the purpose of clinical analysis and medical intervention. The use of this technique revels internal structure that is hidden by the skin and bones for the diagnosis and treatment of disease.

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

World Allergy Diagnostic Market - Opportunities and Forecasts, 2014 - 2020

Allergy is an exaggerated response of immune systems, which causes skin irritation, hay-fever, asthma, anaphylaxis and other symptoms. Therefore, it needs to be diagnosed and treated properly. In order to ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

2017 © Copyright Big Market Research

View Pricing >>